Home › Biliary Tract Cancer › Colorado
Biliary Tract Cancer clinical trials in Colorado
7 studies for Biliary Tract Cancer are looking for participants at sites in Colorado.
Cities in Colorado
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Sarah Cannon Research Institute (SCRI), Denver
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05482893A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Research Site, Aurora
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07221253A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- University of Colorado Anschutz Medical Campus ( Site 0299), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0325), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0326), Aurora
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06428409AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Denver
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Sep 4, 2026 · NCT07038343Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- University of Colorado Denver, Aurora
- UCHealth Highlands Ranch Hospital, Highlands Ranch
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Aug 24, 2026 · NCT05517811Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sarah Cannon Research Institute, Denver
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06239194Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- UCHealth Cancer Care - Anschutz Medical Campus, Aurora
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 5, 2026 · NCT04900818From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.